IS5251A - 9-oxime erythromycin derivatives - Google Patents

9-oxime erythromycin derivatives

Info

Publication number
IS5251A
IS5251A IS5251A IS5251A IS5251A IS 5251 A IS5251 A IS 5251A IS 5251 A IS5251 A IS 5251A IS 5251 A IS5251 A IS 5251A IS 5251 A IS5251 A IS 5251A
Authority
IS
Iceland
Prior art keywords
erythromycin derivatives
oxime erythromycin
oxime
derivatives
erythromycin
Prior art date
Application number
IS5251A
Other languages
Icelandic (is)
Inventor
Wu Yong-Jin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5251A publication Critical patent/IS5251A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IS5251A 1997-06-11 1999-11-16 9-oxime erythromycin derivatives IS5251A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11
PCT/IB1998/000741 WO1998056800A1 (en) 1997-06-11 1998-05-15 9-oxime erythromycin derivatives

Publications (1)

Publication Number Publication Date
IS5251A true IS5251A (en) 1999-11-16

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5251A IS5251A (en) 1997-06-11 1999-11-16 9-oxime erythromycin derivatives

Country Status (31)

Country Link
EP (1) EP0988308A1 (en)
JP (1) JP2000513026A (en)
KR (1) KR20010013660A (en)
CN (1) CN1259135A (en)
AP (1) AP9801253A0 (en)
AR (1) AR012244A1 (en)
AU (1) AU7226798A (en)
BG (1) BG103947A (en)
BR (1) BR9810021A (en)
CA (1) CA2293335A1 (en)
CO (1) CO4940506A1 (en)
CZ (1) CZ9904388A3 (en)
EA (1) EA199901016A1 (en)
GT (1) GT199800074A (en)
HN (1) HN1998000073A (en)
HR (1) HRP980316A2 (en)
HU (1) HUP0002252A3 (en)
ID (1) ID24529A (en)
IL (1) IL132767A0 (en)
IS (1) IS5251A (en)
MA (1) MA26505A1 (en)
NO (1) NO996108L (en)
OA (1) OA11225A (en)
PA (1) PA8451801A1 (en)
PE (1) PE79899A1 (en)
PL (1) PL337606A1 (en)
TN (1) TNSN98083A1 (en)
TR (1) TR199902995T2 (en)
TW (1) TW448174B (en)
WO (1) WO1998056800A1 (en)
ZA (1) ZA985018B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (en) * 1997-10-29 1999-02-09 Monsanto Co DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
AU5299499A (en) 1998-09-22 2000-04-10 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (en) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
US6395710B1 (en) * 1999-04-16 2002-05-28 Kosan Biosciences, Inc. Macrolide antiinfective agents
IL145739A0 (en) 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
ATE250076T1 (en) * 1999-06-07 2003-10-15 Abbott Lab 6-O-CARBAMAT KETOLIDE DERIVATIVES
ID27331A (en) * 1999-09-29 2001-03-29 Pfizer Prod Inc MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
AR043050A1 (en) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8796232B2 (en) 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (en) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド Method for treating malaria, tuberculosis and MAC disease
CN102146085B (en) * 2010-02-09 2014-03-26 北京理工大学 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof
CN103080122A (en) 2010-03-22 2013-05-01 森普拉制药公司 Crystalline forms of macrolides and their uses
WO2011146829A1 (en) 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
JP6042334B2 (en) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド Hydrogen bond forming fluoroketolides for disease treatment
CN104470527B (en) 2012-03-27 2019-05-28 森普拉制药公司 Parenteral formulations for administration of macrolide antibiotics
RU2015138796A (en) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. METHODS AND COMPOSITIONS FOR TREATMENT OF RESPIRATORY DISEASES
WO2014145210A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.

Also Published As

Publication number Publication date
KR20010013660A (en) 2001-02-26
HUP0002252A3 (en) 2002-01-28
GT199800074A (en) 1999-11-27
WO1998056800A1 (en) 1998-12-17
NO996108D0 (en) 1999-12-10
HUP0002252A2 (en) 2000-12-28
EA199901016A1 (en) 2000-06-26
BG103947A (en) 2000-07-31
TR199902995T2 (en) 2000-02-21
HRP980316A2 (en) 1999-04-30
HN1998000073A (en) 1999-01-08
ZA985018B (en) 1999-12-10
AP9801253A0 (en) 1999-12-04
CZ9904388A3 (en) 2002-10-16
EP0988308A1 (en) 2000-03-29
AR012244A1 (en) 2000-09-27
PE79899A1 (en) 1999-08-25
PL337606A1 (en) 2000-08-28
IL132767A0 (en) 2001-03-19
BR9810021A (en) 2000-09-19
AU7226798A (en) 1998-12-30
JP2000513026A (en) 2000-10-03
PA8451801A1 (en) 2000-05-24
TW448174B (en) 2001-08-01
MA26505A1 (en) 2004-12-20
CN1259135A (en) 2000-07-05
OA11225A (en) 2003-07-17
ID24529A (en) 2000-07-20
TNSN98083A1 (en) 2005-03-15
NO996108L (en) 2000-02-10
CO4940506A1 (en) 2000-07-24
CA2293335A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
ATE310742T1 (en) C-4ß-SUBSTITUTED MACROLIDE DERIVATIVES
ATE377018T1 (en) ERYTHROMYCIN DERIVATIVES
IS5528A (en) New macrolide
IL132767A0 (en) 9-Oxime erythromycin derivatives
NO993876D0 (en) 3'-N-oxide, 3'-N-dimethylamine, 9-oxime erythromycin A derivatives
DK0941998T3 (en) 3,6-ketal macrolide antibiotics
NO20015172D0 (en) 1-Methyl erythromycin derivatives
EE200100394A (en) Ketolide antibiotics
EE200100245A (en) New macrolide antibiotics
DK1027362T3 (en) 2-halo-6-O-substituted ketolide derivatives
ATE257484T1 (en) 6,9-BRIDGED ERYTHROMYCIN DERIVATIVES
ATE239750T1 (en) 6,11-BRIDGED ERYTHROMYCIN DERIVATIVES
NO980016D0 (en) Macrolides
EP1167375A4 (en) ERYTHROMYCIN DERIVATIVES
LV11898A (en) Erythromycin derivatives
EP0766685A4 (en) MACROLIDES ARYLES, ALKYLES, ALCENYLES ET ALCYNYLES
ZA983902B (en) Erythromycin derivatives.
EP1044985A4 (en) ERYTHROMYCIN DERIVATIVES
PT984975E (en) MULTICICULAR ERYTHROMYCIN DERIVATIVES
BR1100453A (en) erythromycin derivatives
GB9700702D0 (en) Erythromycin derivatives
ZA989845B (en) 2-halo-6-O-substituted ketolide derivatives
SI1027362T1 (en) 2-halo-6-o-substituted ketolide derivatives